Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss SGMO - Sangamo Therapeutics, Inc.
-4.6 M
LAST VALUE
-7.35%
2 YEAR CAGR
-26.12%
5 YEAR CAGR
-81.31%
10 YEAR CAGR